Thus, although extensive methylation in MGMT and SFRP2 has a similar feature in terms of association with CRC with KRAS mutations, all POLE-mutant tumours demonstrated extensive methylation in SFRP2, but no methylation in MGMT. This evidence concerns the gene SFRP2 and colorectal carcinoma.